For NHS dispensing practices

Find the dispensary margin your practice is losing.

Built and run by dispensing GPs. A live market dashboard your whole practice uses every day, and a tailored deep-dive that turns your own prescribing into recovered margin.

Built and run by dispensing GPsLive data, refreshed every working dayUK-hosted and access-controlled
Built by dispensing GPs UK-hosted & access-controlled Live market data, every working day
See it working

The live market, and what is moving it.

On the left, the live market dashboard your whole practice can use every working day. On the right, the latest from Tariff Watch. This is the heart of RxMargin.

Live Market Live
Lines tracked
18,125
In stock now
10,068
Citalopram 20mg tablets best margin £2.33
NHS reimb PSUK AAH Alliance  out of stock
Updated 04 Jun 2026 Open demo →
Open the live demo →
Individual logins for your whole team. Demo names anonymised; subscribers see live, named data.
Tariff Watch Jun 2026
3 Jun 2026Concessions
Ten May price concessions roll over into June 2026
CPE confirms 10 lines, including atorvastatin 60mg at £4.37 and ticagrelor 90mg at £4.18, carry May's agreed price into June. Source: CPE.
2 Jun 2026Concessions
May 2026 sets a record at 230 price concessions
The third record-breaking month running (March 201, April 204) as supply-market instability pushes more generics above tariff price. Source: CPE.
29 May 2026Reimbursement
2026/27 deal lifts retained medicine margin to £1.1bn
The settlement raises the margin pool by £200m and writes off historic over-delivery, delivered through the Category M Tariff prices dispensers are also paid at. Source: DHSC / CPE.
28 May 2026Shortages
Seven Serious Shortage Protocols active into summer 2026
NHSBSA lists SSPs covering ramipril 1.25mg, Creon 10000/25000 and Estradot HRT patches; dispensers are paid for the quantity actually supplied. Source: NHSBSA.
27 May 2026Drug Tariff
June 2026 Drug Tariff resets reimbursement on multiple lines
Budesonide 3mg capsules cut from £75.05 to £60.00, naproxen 250mg/5ml suspension doubled to £90.09, with eight deletions and new additions. Source: CPE.
4 May 2026Contract
Dispensary Services Quality Scheme: sign up by 30 June
DSQS remains an opt-in per-patient quality payment for 2026/27, requiring SOPs, a clinical audit and a DRUM across 10% of the dispensing list. Source: THC Primary Care.
16 Apr 2026Concessions
Why concessions matter: co-codamol up 56%, propantheline near five-fold
Concessions flag generics that cannot be bought at tariff price; for a dispensary the uplift is the difference between a loss and a fair margin. Source: The Pharmaceutical Journal.
15 Apr 2026Reimbursement
April Category M reprice cuts high-volume DOACs and gliptins
619 products repriced, with dapagliflozin, rivaroxaban and sitagliptin among the fallers, despite a £20m quarterly margin uplift. Source: Dispex.
1 Apr 2026Contract
Dispensing fee scale cut by an average 2.85% from April 2026
The DDA reports a 6.33p-per-item reduction versus October 2025, reversing the autumn uplift on the core dispensing income stream. Source: DDA.
24 Feb 2026Reimbursement
Dispensing practices still pay full clawback on concession lines
Unlike pharmacies, dispensing doctors are excluded from Discount Not Deducted status on concessions, a gap the DDA estimates at up to £40,000 per practice a year. Source: CPE / DDA.
20 Jan 2026Suppliers
Phoenix, the parent of PSUK, rolls out AI stock forecasting
Phoenix Healthcare Distribution adopts RELEX AI forecasting across 12 UK depots serving 7,100+ pharmacies and dispensing practices, aiming to improve availability. Source: RELEX.
Read all Tariff Watch →
Dated and sourced. Refreshed as the Tariff and concessions move.
Two ways to work with us

A live subscription, and a tailored deep-dive.

The subscription keeps the whole dispensing market in front of you every day. The tailored report turns your own history into, typically, around £50,000 of identified recoverable margin (depending on list size). Most practices start with the subscription and add the report.

Subscription

RxMargin Live Market

Live dashboard · flat monthly fee · nothing to set up
  • Up-to-date prices across all three main wholesalers, side by side
  • The latest Drug Tariff and price concessions, and what they mean for your margin
  • Today's biggest winners and losers, and the cheapest supplier in stock
  • 90-day price history and a universal prescriber-switching view
  • Individual logins for your whole team, under one practice subscription
Open the live demo →
Whole-practice subscription · pricing TBC
Tailored report

Dispensary deep-dive

Practice-specific analysis · live findings call with the founders
  • A deep dive into your practice's own dispensing history, from your invoices, FP34 and ePACT2 data
  • Every profitable prescribing switch quantified: generic-to-brand rebate lines (NHS impact shown), inhalers, the flozins, emollients and more
  • NHS contract modelling, a QOF review, and local population and housing-growth research for your area
  • Priority access to exclusive MDS and manufacturer rebate schemes
  • A live Teams readout with the founders, and an optional hands-off implementation
Book a dispensary review →
Typically identifies ~£50k, depending on list size

The live dashboard keeps you ahead day to day. The tailored report is a one-off deep dive that recovers margin you are currently missing. The two work together.

Why practices trust the numbers

Proven on a live practice
The method was built and run against a working NHS dispensing practice, not a demo.
Reconciles to your FP34
Income is audited back to source, to within a fraction of a percent, before anything is reported.
Signed off by a dispensing GP
Every material figure is checked by a GP who dispenses, never generated and left unchecked.
Live, every working day
The market dashboard refreshes daily from the wholesalers, the Drug Tariff and the concessions.
What it does

A clear, live picture of where your dispensary stands.

Reimbursement, the Drug Tariff, concessions, rebates and procurement all move independently, and a line that made money last quarter can quietly turn into a loss. RxMargin tracks it line by line and refreshes every working day, so the whole market is in front of you in seconds, not minutes.

Drug-level margin

Net cost versus reimbursement on every line, so loss-making and over-tariff items surface instead of hiding in the average.

Rebates & concessions

Supplier rebate schemes and live price concessions tracked, flagging where you are below the rates you could earn.

Cheapest supplier, in stock

The best in-stock price for any line across the wholesalers, with 90-day history, so you always buy well.

Built for speed

What used to take minutes takes seconds, handing hours back to your dispensary team every week.

Included with the subscription

A prescriber view for the whole team, with prices kept private.

Every prescribing clinician gets their own login showing the practice's preferred lines at the point of prescribing. Costs, margins and figures stay with the partners. That is what makes better prescribing stick, without ever exposing commercially sensitive data to the wider team.

  • Every prescriber, one shared view

    Not just the partners. Salaried GPs, registrars, ANPs and practice pharmacists all see the same agreed preferred lines, so the whole team prescribes from the same page.

  • Preferred lines at the point of prescribing

    The recommended product, form and pack for each therapeutic choice, with the clinically equivalent alternative alongside. Good decisions happen as the script is written, not audited months later.

  • Price-blind by design

    The prescriber view never shows cost, margin or any figure. Commercial data stays with the partners and practice manager, which is exactly why partners are comfortable rolling access out to everyone.

portal.rxmargin.co.uk/formulary
Dr A. PrescriberPrescriber view
Formulary only
Type 2 diabetes · SGLT2 inhibitor
Preferred
Dapagliflozin 10mg
28 tablets, once daily
Hidden
Alt
Empagliflozin 10mg
clinically equivalent option
Hidden
Respiratory · ICS/LABA inhaler
Preferred
Fostair 100/6 pMDI
2 puffs twice daily
Hidden
Prices visible to partners and the practice manager only

The result: partners keep commercial data private, prescribers get clean clinical guidance, and the whole practice moves to its preferred lines together. It is a secure portal page, not another system to install: we set up a login for each prescriber, onboarding takes minutes, and it opens in the browser alongside your clinical system. Talk to us about practice-wide access →

How it works

The live market is instant. The report works from your data.

1

Share your data

Dispensing data, wholesaler invoices and remittances, sent securely. We provide a simple checklist.

2

We analyse

Our audited workflow reconciles every line and audits the figures before anything is reported.

3

You review

Dashboards and reports appear in your private portal, only your practice and our team can see them.

4

You act

A prioritised list of recoverable margin, with the value at stake on each line, ready to act on.

See the full method, the line-level maths and the engine behind it →  ·  Or read the latest Tariff Watch →

Security & information governance

Built to be safe to put practice data on.

We treat your data the way a practice has to. Hosting is in the UK, every practice is isolated, and access is by individual sign-in, there's no shared login and no open link.

Per-practice isolation

Each practice can only reach its own material. One practice physically cannot fetch another's files, access is blocked before the request is served.

Individual sign-in

Each named user signs in with a one-time code to their own email. No shared passwords for you to manage, and access can be removed in seconds.

UK-hosted

Content is served from the UK behind an access-controlled front door, so practice material never sits on an open address.

Aggregate, not patient data

The analysis uses practice-level dispensing, tariff and invoice data (drug, pack, cost and reimbursement). It uses no patient-identifiable records and nothing from the clinical record, which keeps the governance burden proportionate.

DSPT and a written DPA

We align to the NHS Data Security and Protection Toolkit and sign a data-processing agreement with your practice. You remain the data controller; we are your processor, with a defined retention and deletion policy.

Computed by rule, audited by a GP

Every reimbursement, cost and margin figure is computed by rule against the Drug Tariff, never guessed or estimated. No patient-identifiable data is involved, and a dispensing GP checks every material number against source and signs it off.

We provide a data-processing agreement, our DSPT position and our retention and deletion policy before any real practice data is shared.

Why RxMargin

Specialist analysis, not generic software.

Who builds it

RxMargin is built and run by practising NHS GPs who dispense. The method was developed against real dispensing data from a working practice, encodes how a dispensary actually trades, and every material figure is audited by a dispensing GP before it reaches your portal, not generated and left unchecked.

The founders
E
Dr Edward Muffett
Founder and Technical Director
GP

A practising NHS GP with a keen interest in software development and how technology can transform the NHS and improve its efficiency. Ed built the RxMargin engine that turns raw tariff, invoice and dispensing data into recoverable margin.

M
Dr Mark Piper
Co-Founder and Clinical Director
Senior GP partner at a dispensing practice

A senior partner at a dispensing practice with years of experience and a sharp financial awareness of how a dispensary actually runs. Mark grounds every figure in the day-to-day reality of dispensing.

Understood by people who dispense
Built and run by dispensing GPs, so the analysis reflects how a real dispensary actually operates, not a generic template.
Depth other tools skip
Margin, rebate and concession analysis at the line level, where the money genuinely moves.
A managed service
You don't learn new software or wrestle with data. You receive finished, audited analysis through a private portal.
Private by design
Each practice sees only its own material, behind individual sign-in, hosted in the UK.
Pricing

Two products, priced to match the value.

Final pricing is being confirmed. The Live Market subscription is a flat, ongoing fee for the whole practice. The tailored deep-dive is a one-off engagement, sized to your list. Most practices begin with the subscription and add the report when they want the full picture.

Live Market Subscription
The whole dispensing market, live, shared across the practice and the prescribing team.
TBCflat monthly fee
What the subscription represents:
  • One universal dashboard, refreshed every working day, nothing to set up
  • Live wholesaler prices and stock, the Drug Tariff and every price concession
  • Today's biggest margin winners and losers, and the cheapest supplier in stock
  • The price-blind Prescriber Dashboard, with a login for every prescriber
  • One subscription for the whole practice, cancel with 30 days' notice
Register your interest →
Tailored Report Deep-dive
A one-off, practice-specific recovery of the margin your own history is leaving behind.
TBCone-off, sized to your list
What the deep-dive covers:
  • Your dispensing history analysed line by line, reconciled to FP34 and ePACT2
  • Every profitable prescribing switch quantified, with the NHS impact shown
  • NHS contract modelling, a QOF review, and local population and housing-growth research
  • A live Teams readout with the founders, and an optional hands-off implementation
  • Typically identifies around £50,000, depending on list size
Book a dispensary review →

Pricing scales with list size, so a smaller practice pays less overall. We confirm the exact figure for your list size after an initial look. Prices will exclude VAT.

No-obligation first look: from a single period of your data we tell you whether there is enough recoverable margin to be worth your while, before you commit to anything.

Common questions

What practices ask us first.

What do you need from us to start?
Nothing for the Live Market subscription, it is live the moment you sign in. For a tailored report we ask for your dispensing data (e.g. PD4(PxQ)), recent wholesaler invoices and supplier remittances, with a short checklist and a secure way to share them. No new software for your team to learn.
How is this different from what our accountant does?
Accountants work at the year-end, whole-dispensary level. We work at the individual drug-line level, every period, reconciling each line against what you were actually reimbursed and against the rates and concessions available that month. It complements your accountant; it doesn't replace them.
Is our data safe?
Yes. Each practice is isolated behind its own individual sign-in, hosted in the UK, with no shared link or login. The data we use is practice-level (dispensing, tariff and invoice figures), not patient-identifiable records. We provide a data-processing agreement before anything is shared.
Will this conflict with NHS prescribing guidance or our ICB?
No. Every switch we suggest shows its effect on the NHS bill, not just your margin. Where moving to a brand to claim a manufacturer rebate would cost the NHS more, we say so on the line and flag the extra per pack; we only present a switch as a clean win when it is cost-neutral or saves the NHS money. The clinician always decides what is clinically appropriate. We surface the figures, we do not prescribe.
How much time would it take us?
Minimal. The Live Market subscription needs nothing set up. For a tailored report you share your data once; the analysis, reconciliation and reporting are done for you and delivered ready to act on.
What do we actually get back?
From the Live Market subscription: the live market dashboard and the price-blind prescriber view, updated every working day, with an individual login for everyone on the team. From a tailored report: partner-ready reports, ready-to-send submissions (such as a price-concession claim) and a prioritised list of recoverable margin, delivered through your private portal.
What does it cost?
Final pricing is being confirmed. The Live Market dashboard is a flat monthly subscription for the whole practice; the tailored deep-dive is a one-off engagement sized to your list. Pricing scales with list size, so a smaller practice pays less overall, and we confirm the exact figure after an initial look. No long tie-in; 30 days' notice on the subscription. See what each product includes →
We see a certificate error when visiting from our surgery computer. Why?
NHS-managed networks often run TLS inspection - they re-sign web traffic with a local certificate that your browser does not recognise. This produces a "Your connection is not private" or NET::ERR_CERT_AUTHORITY_INVALID warning. The site itself is fine; the warning is caused by the network layer, not by anything wrong with rxmargin.co.uk.

Your IT team or helpdesk can fix it in about two minutes by adding four hostnames to two policy rules in Cloudflare Gateway (a "Do Not Inspect" TLS rule and an Allow HTTP rule). The hostnames are: rxmargin.co.uk, www.rxmargin.co.uk, portal.rxmargin.co.uk and rxmargin.cloudflareaccess.com.

Download the full allowlisting instructions to share with your IT team →

For SCW-managed practices, raise a network-related call via the SCW IT Self Service Portal and reference those instructions. In the meantime, the site works normally from any device not on the NHS-managed network (a personal phone or laptop, for example).
Latest from Tariff Watch

What is moving margin this month.

A short, dated read on the Drug Tariff, contract and QOF changes that move dispensing income. Read the full Tariff Watch →

Last updated: June 2026

Concessions · Jun 2026
May 2026 set a record at 230 price concessions
The third record-breaking month running, after 201 in March and 204 in April. Each concession lifts reimbursement above tariff, but only for that month, so timing is everything.
Reimbursement · 29 May 2026
2026/27 deal lifts retained medicine margin to £1.1bn
The settlement adds £200m to the margin pool and writes off historic over-delivery, fed through the Category M Tariff prices that dispensing practices are also paid at.
Contract · 1 Apr 2026
Dispensing fee scale cut by an average 2.85%
The DDA reports a 6.33p-per-item reduction from April 2026 versus October 2025, reversing the autumn uplift on the core dispensing income stream just as staff costs rise.
Get in touch

See what RxMargin finds in your dispensary.

Email us about an initial review and we'll explain what we'd need and what you'd get back. The first look is no-obligation: we'll tell you, from a single period of data, whether there's enough recoverable margin to be worth your while before you commit to anything.

No obligation. We reply by email, usually within two working days.
Prefer email? hello@rxmargin.co.uk  ·  Already a client? Sign in to your portal →